In particular, longer telomere length values are proven to be associated with mutations in the epigenetic modifying enzymes, the IDH1/2 genes; a positive relationship has been observed between IDH mutations and positive clinical outcomes in AML [196]. The gene discussed is IDH1; the disease is acute myeloid leukemia.